HCLTech reported a 21.2 per cent rise in net profit at ₹5,132 crore in the second quarter of financial year 2027, up from ₹4,235 crore in the corresponding quarter last year.
He expects markets to go through a consolidation phase before a sustained recovery, advising investors to deploy money gradually over the next two to three quarters.
Emcure Pharmaceuticals will merge its wholly owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, with itself under the proposed scheme.
The company said it did not received any specific notice, order or communication from FSSAI or the Tamil Nadu Food Safety Department directing an inquiry into the Company's Paneer products
Till Nifty 50 holds below 23,200 zones weakness could extend towards 23,050 then 22,950 levels while on the upside hurdles can be seen at 23,350 then 23,450 zones.
The issue is a combination of fresh issue of 2.66 crore shares aggregating to ₹675 crores and offer for sale of 78.74 lakh shares aggregating to ₹200 crores.